Discover
TMDX
TransMedics Group, Inc.
67.85
2 x 50.91
2 x 86.88
bid
ask
+
1.43
2.15%
2 @ 04:00 PM
68.81 +0.96 (1.42%)
| Ytd | -44.23% | |
| 1y | -46.86% |
67.44
day range
71.67
60.10
52 week range
156.00
| Open | 67.68 | Prev Close | 66.42 | Low | 67.44 | High | 71.67 | Mkt Cap | 2.34B |
| Vol | 1.05M | Avg Vol | 1.34M | EPS | 4.37 | P/E | 15.53 | Forward P/E | 21.20 |
| Beta | 1.88 | Short Ratio | 6.27 | Inst. Own | 108.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 77.74 | 200-d Avg | 113.58 | 1yr Est | 117.33 |
| Income Statement | |||
| Total Revenue | 173.93M | ||
| Revenues (USD) | 173.93M | ||
| Cost of Revenue | 72.77M | ||
| Gross Profit | 101.16M | ||
| Operating Expenses | 87.86M | ||
| Research and Development Expense | 24.88M | ||
| Selling, General and Administrative Expense | 62.99M | ||
| Operating Income | 13.30M | ||
| Interest Expense | 7.17M | ||
| Income Tax Expense | 1.17M | ||
| Net Income | 7.32M | ||
| Net Income Common Stock | 7.32M | ||
| Net Income Common Stock (USD) | 7.32M | ||
| Consolidated Income | 7.32M | ||
| Earnings per Basic Share | 0.21 | ||
| Earnings per Basic Share (USD) | 0.21 | ||
| Earnings per Diluted Share | 0.20 | ||
| Earning Before Interest & Taxes (EBIT) | 15.66M | ||
| Earning Before Interest & Taxes (USD) | 15.66M | ||
| Weighted Average Shares | 34.38M | ||
| Weighted Average Shares Diluted | 36.19M | ||
| Balance Sheet | |||
| Cash and Equivalents | 480.18M | ||
| Cash and Equivalents (USD) | 480.18M | ||
| Trade and Non-Trade Receivables | 90.73M | ||
| Current Assets | 619.28M | ||
| Property, Plant & Equipment Net | 700.97M | ||
| Total Assets | 1.43B | ||
| Debt Current | 18.51M | ||
| Total Debt | 863.42M | ||
| Current Liabilities | 91.92M | ||
| Debt Non-Current | 844.91M | ||
| Total Liabilities | 940.81M | ||
| Accumulated Retained Earnings (Deficit) | -270.63M | ||
| Accumulated Other Comprehensive Income | 2.00K | ||
| Shareholders Equity | 494.01M | ||
| Shareholders Equity (USD) | 494.01M | ||
| Assets Non-Current | 815.54M | ||
| Total Debt (USD) | 863.42M | ||
| Deferred Revenue | 2.95M | ||
| Goodwill and Intangible Assets | 11.55M | ||
| Inventory | 49.89M | ||
| Liabilities Non-Current | 848.89M | ||
| Trade and Non-Trade Payables | 11.15M | ||
| Tax Assets | 82.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.47M | ||
| Net Cash Flow from Financing | 3.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.69M | ||
| Capital Expenditure | -36.66M | ||
| Issuance (Purchase) of Equity Shares | 3.90M | ||
| Net Cash Flow from Investing | -36.66M | ||
| Net Cash Flow from Operations | 24.53M | ||
| Effect of Exchange Rate Changes on Cash | -327.00K | ||
| Share Based Compensation | 9.95M | ||